Skip to main content
Caplight Logo









Caelus Health

Caelus Health

Private
AmsterdamHealthcare & Life Scienceshttps://caelushealth.com

Last Round

Strategic

Nov 25, 2019

Total Funding Raised

$4.71M

Company Overview

Caelus Health operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Strategic round in November 2019.

Caelus Health is a biotechnology company that develops microbiota-based therapeutics and functional food products for the prevention and treatment of cardiometabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Caelus Health Comparables

Compare Caelus Health with similar companies based on industry and business-model similarity.

Caelus Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MRM Health
76%
Beo Therapeutics
71%
Advanced Microbiome Interventions
71%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Caelus Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 25, 2019
DebtJan 26, 2017
Series AJan 26, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Caelus Health Investors

Notable investors and investment history

Caelus Health investors
InvestorRounds
Johnson & Johnson Innovation - JJDC, Inc.Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 25, 2025

    Grew 200% QoQ from 3 to 9 employees.

  • Jan 24, 2025

    Grew 250% QoQ, from 2 to 7 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Caelus Health Filings

Explore SEC and related filing metadata, where available.

Caelus Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Caelus Health's valuation, stock price, and market status.

Is Caelus Health a public or private company?

Caelus Health is a private company.

What is the current stock price of Caelus Health?

Caelus Health is a private company, so its shares have no public market price. Caplight tracks Caelus Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Caelus Health worth (valuation)?

Valuation information for Caelus Health is not publicly available.

Can I buy Caelus Health stock?

Caelus Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Caelus Health's last funding round?

Caelus Health's most recent funding round was Strategic on November 25, 2019.

Who are the main investors in Caelus Health?

Key investors in Caelus Health include Johnson & Johnson Innovation - JJDC, Inc..

Will Caelus Health IPO soon?

No public IPO plans have been announced for Caelus Health.

How can I track Caelus Health secondary market activity?

Caplight tracks bids, offers, and trades in Caelus Health's shares on secondary markets.

Firmographic Details

HeadquartersAmsterdam
Employee Range9
Year Founded2014
Last FundingNov 25, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?